Back to Forecasting
MDBActive

Will MongoDB's Q1 FY2027 Atlas revenue growth decelerate below 21% year-over-year?

Resolves June 15, 2026(91d)
IG: 0.60

Current Prediction

20%
Likely No
Model Agreement80%
Predictions9 runs
Last UpdatedMarch 15, 2026

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 15%30%Aggregate: 20%
Individual Predictions(9 runs)
opusRun 1
18%

The 21% threshold is the low end of management's own FY2027 Atlas guidance range (21-23%), and MongoDB has a deeply entrenched beat-and-raise pattern — FY2026 initial guidance was beaten by 9.5%, and every quarterly guide was exceeded. Q4 FY2026 Atlas grew 29% against ~27% guidance. Even accounting for guided deceleration, historical patterns strongly suggest Q1 will land above the low end of full-year guidance. The CRO departure is a genuine execution risk for new logo acquisition, but Atlas consumption revenue from existing customers (net ARR expansion at 121%, 3rd consecutive improvement) is less sensitive to sales leadership changes. Back-loaded deceleration is the historical pattern — Q1 typically comes in strong with guidance raises through the year. I estimate 18% probability of falling below 21%.

21% is the low end of management's own guidance — beating the bottom of your own range is a low barFY2026 beat-and-raise pattern: 9.5% full-year beat, every quarter exceededBack-loaded deceleration is the historical pattern; Q1 typically outperforms full-year guide
opusRun 2
28%

I weigh execution risk and structural deceleration more heavily. The CRO departure during a guided deceleration year is not trivial — this is the 3rd CFO rotation plus new CEO, President of Field Ops, and now CRO vacancy within 18 months. Governance alignment has been escalated to CONCERNING. The FY2027 guidance represents the steepest guided deceleration in MongoDB's public history (from 29% actual to 21-23% guided). While MongoDB typically beats guidance, the magnitude of this step-down suggests management sees genuine headwinds — possibly harder comps against FY2026's acceleration, macro uncertainty, or sales org disruption they can't fully quantify. The Q1 FY2026 Atlas comp is 26%, which is not easy to grow against. If any macro disruption hits (tariffs, rate uncertainty), the 75% consumption-based model is vulnerable. The pipeline was built before the CRO left, but deal conversion under a GTM leadership vacuum may suffer for larger enterprise deals. 28% probability.

CRO departure + cumulative executive churn (3 CFOs, new CEO, CRO) = CONCERNING governance alignmentSteepest guided deceleration in MDB's public history suggests genuine structural headwinds75% consumption-based revenue remains macro-sensitive — April 2025 tariff episode proved this
opusRun 3
15%

The math strongly favors NO. Atlas crossed $2B annualized run rate in Q4 FY2026. If Q4 Atlas revenue was approximately $500M (29% YoY growth), then Q1 FY2026 Atlas was approximately $397M (implied by 26% growth that quarter off FY2025 base). To grow below 21%, Q1 FY2027 Atlas would need to come in below ~$480M. Given RPO surged 97% to $1,470M — nearly doubling contracted future revenue — and net ARR expansion improved for the 3rd straight quarter to 121%, the consumption floor is well-supported. MongoDB's guidance beat history shows systematic 4-10% beats on revenue. Even if the beat magnitude compresses to 2-3% (accounting for real deceleration), that still puts Atlas growth at 23-25%, well above 21%. The only scenario for sub-21% is a severe macro shock or a catastrophic GTM failure from the CRO vacancy, both low-probability in a 3-month window. 15% probability.

RPO +97% YoY ($1,470M) provides strong contracted revenue floor for near-term quartersSub-21% requires Atlas revenue below ~$480M — inconsistent with 121% net ARR expansion and $2B+ run rateEven a compressed 2-3% guidance beat (vs historical 4-10%) lands Atlas at 23-25% growth
sonnetRun 1
22%

MongoDB guided FY2027 Atlas at 21-23% growth, meaning 21% is their own floor estimate. Their track record of beating guidance is strong — FY2026 initial guidance was beaten by 9.5% and Q4 Atlas came in at 29% vs ~27% guided. The predecessor market (Q4 below 25%) resolved at NO with Atlas growing 29%, and the ensemble correctly predicted that outcome. However, this market is structurally different: the deceleration from 29% to the 21-23% range is real and guided. The CRO vacancy adds execution uncertainty, though Q1 pipeline was largely built. Net ARR expansion at 121% and platform deepening at 44% multi-product adoption support existing customer consumption. Historical pattern favors Q1 outperforming the full-year guide. I assess 22% probability that Atlas falls below 21%.

21% is management's own floor — their beat history makes falling below the floor unlikelyPredecessor market correctly predicted Q4 would beat threshold; similar dynamics apply hereQ1 pipeline was substantially built before CRO departure, limiting near-term execution impact
sonnetRun 2
30%

I take a more cautious view emphasizing the governance and execution risks. The cumulative executive churn is unprecedented for MongoDB — 3 CFOs, new CEO, new President of Field Ops, and now the CRO departed with no replacement. This level of leadership instability during a guided deceleration year creates real execution risk beyond what pipeline coverage can mitigate. The Insider Investigator escalated GOVERNANCE_ALIGNMENT to CONCERNING, and the Myth Meter flagged NARRATIVE_REALITY_GAP as DIVERGING. The Q1 FY2026 Atlas comp is 26% — not trivial to grow against even with strong consumption trends. Management's guidance of 21-23% may actually be less conservative than usual given the leadership disruption they're navigating. If deceleration is front-loaded rather than back-loaded, Q1 could come in at 21-22%, making the below-21% scenario more plausible than the consensus suggests. 30% probability.

Unprecedented executive churn: 3 CFOs + new CEO + CRO vacancy within 18 monthsGOVERNANCE_ALIGNMENT escalated to CONCERNING + NARRATIVE_REALITY_GAP DIVERGINGFront-loaded deceleration scenario puts Q1 at 21-22%, making sub-21% a near-miss possibility
sonnetRun 3
17%

The operational momentum is hard to ignore. Q4 FY2026 delivered 29% Atlas growth, 7x FCF improvement, first positive GAAP operating income, and net ARR expansion at 121% (3rd consecutive improvement). The Atomic Auditor rated execution as EXCEEDING with MEDIUM-HIGH confidence. Customers using 2+ products reached 44% (up from 36%), indicating deepening platform adoption that sustains consumption independent of new logo acquisition. RPO nearly doubled to $1,470M, providing a strong contracted revenue floor. MongoDB's historical deceleration pattern is back-loaded — Q1 typically exceeds full-year guidance pace. For Atlas to fall below 21%, essentially every positive operational trend would need to reverse simultaneously while the business is executing at its best-ever margins. I assign 17%.

Atomic Auditor EXCEEDING classification + 7x FCF improvement signals peak operational execution44% multi-product adoption (up from 36%) deepens consumption stickinessBack-loaded deceleration pattern means Q1 historically outperforms full-year guide pace
haikuRun 1
20%

MongoDB guided 21-23% Atlas growth for FY2027. The 21% threshold is the floor of their own guide, and they've beaten guidance by 9.5% on a full-year basis in FY2026. Beat-and-raise history makes falling below the floor unlikely. CRO vacancy is a risk but Q1 pipeline was pre-built. Net ARR expansion at 121% supports consumption growth. 20% probability.

21% is the floor of management's own guidance rangeFY2026 full-year beat of 9.5% demonstrates systematic conservatismNet ARR expansion at 121% supports consumption growth floor
haikuRun 2
25%

The CRO departure during a steep guided deceleration year creates meaningful uncertainty. While existing customer consumption should hold (121% net ARR expansion), new enterprise deal velocity may suffer from the GTM leadership vacuum. The 26% Q1 FY2026 comp is a harder base than earlier quarters. Macro sensitivity at 75% consumption-based adds tail risk. Still, 21% is a low bar relative to recent performance (29% in Q4). 25% probability.

CRO vacancy may slow enterprise deal velocity in Q126% Q1 FY2026 comp creates harder base effect75% consumption-based model adds macro sensitivity risk
haikuRun 3
19%

RPO surged 97% to $1,470M, providing strong forward visibility. Platform deepening at 44% multi-product adoption and net ARR expansion at 121% create a high consumption floor. MongoDB's deceleration pattern historically favors strong Q1 with guidance raises through the year. The $2B Atlas run rate and 65,200 customer base provide scale resilience. The 21% bar is very low relative to these fundamentals. 19% probability.

RPO +97% ($1,470M) provides exceptional forward revenue visibilityPlatform deepening (44% multi-product) and 121% net expansion create consumption floorHistorical pattern: Q1 outperforms full-year guide, raises come later

Resolution Criteria

Resolves YES if MongoDB's Q1 FY2027 earnings release (expected June 2026) reports Atlas revenue year-over-year growth below 21%. Resolves NO if Atlas growth is 21% or above.

Resolution Source

MongoDB Q1 FY2027 earnings release (expected June 2026)

Source Trigger

Atlas growth rate vs. 21-23% FY2027 guidance — escalate REVENUE_DURABILITY if below 20%; de-escalate CONDITIONAL if above 23%

gravy-gaugeREVENUE_DURABILITYHIGH
View MDB Analysis

Full multi-lens equity analysis